Back
Kymera Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
KYMR
Kymera Therapeutics, Inc.
Last Price:
$90.10
Seasonality Move:
-21.77%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and KYMR is experiencing slight selling pressure.
Kymera Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 89.44 | Buy |
| 20-day SMA: | 83.31 | Buy |
| 50-day SMA: | 78.86 | Buy |
| 200-day SMA: | 57.83 | Buy |
| 8-day EMA: | 89.55 | Buy |
| 20-day EMA: | 84.72 | Buy |
| 50-day EMA: | 79.03 | Buy |
| 200-day EMA: | 62.31 | Buy |
Kymera Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.45 | Buy |
| Relative Strength Index (14 RSI): | 66.75 | Buy |
| Chaikin Money Flow: | -21482 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.85 - 88.11) | Buy |
| Bollinger Bands (100): | (61.35 - 82.61) | Buy |
Kymera Therapeutics, Inc. Technical Analysis
| Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics, Inc. Stock
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 91.35 while KYMR 8-day simple moving average is 89.44, which is a Buy signal.
-
The stock price of KYMR is 91.35 while Kymera Therapeutics, Inc. 20-day SMA is 83.31, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day simple moving average is 78.86 while KYMR share price is 91.35, making it a Buy technically.
-
KYMR stock price is 91.35 and Kymera Therapeutics, Inc. 200-day simple moving average is 57.83, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
68
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy or a Sell?
-
Kymera Therapeutics, Inc. stock is rated a BuyThe current Kymera Therapeutics, Inc. [KYMR] share price is $91.35. The Score for KYMR is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics, Inc. Stock Info
Market Cap:
6.6B
Price in USD:
91.35
Share Volume:
1.2M
Kymera Therapeutics, Inc. 52-Week Range
52-Week High:
103.00
52-Week Low:
19.45
Buy
68
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Kymera Therapeutics, Inc. Share Price Forecast
-
What is the Kymera Therapeutics, Inc. stock price today?The Kymera Therapeutics, Inc. stock price is 91.35 USD today.
-
Will KYMR stock go up or go down?Kymera Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Kymera Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics, Inc. is not overvalued.
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 91.35 while KYMR 8-day exponential moving average is 89.55, which is a Buy signal.
-
The stock price of KYMR is 91.35 while Kymera Therapeutics, Inc. 20-day EMA is 84.72, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day exponential moving average is 79.03 while KYMR share price is 91.35, making it a Buy technically.
-
KYMR stock price is 91.35 and Kymera Therapeutics, Inc. 200-day simple moving average is 62.31, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics, Inc.
Is Kymera Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.46 per share.
Technical Analysis of Kymera Therapeutics, Inc.
Should I short Kymera Therapeutics, Inc. stock?
-
KYMR Moving Average Covergence Divergence (MACD) indicator is 4.45, suggesting Kymera Therapeutics, Inc. is a Buy
-
Kymera Therapeutics, Inc. Relative Strength Index (RSI) is 66.75, which suggest Kymera Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Kymera Therapeutics, Inc. is (73.85 - 88.11), which suggest Kymera Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Kymera Therapeutics, Inc. is (61.35 - 82.61), which suggest Kymera Therapeutics, Inc. is a Buy
* Kymera Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.